SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Premier Research Worldwide [NASDAQ: PRWW]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Champolion who wrote (4)5/20/1999 10:36:00 PM
From: TallTrader  Read Replies (2) of 33
 
What proof do you have?

From their 4/26/99 press release, they say they have a "consulting agreement" with AmericasDoctor.com and can "use its Internet capabilities."

Where did you get your info that PRWW has a "stake" in AmericanDoctor.com?

4/26/99 press release:

"We also announced in the first quarter of 1999 a consulting agreement
with AmericasDoctor.com to enhance this Internet company's capability to
effectively support patient identification, recruitment and referral to
clinical investigational sites for both PRWW and other companies in the
pharmaceutical, biotechnology and medical device industries. This solidifies
our position with AmericasDoctor.com to use its Internet capabilities and its
relationship with America Online to help us find patients faster to complete
clinical trials sooner. We all know that patient recruitment is the single
most frequently mentioned reason for delays in completion of clinical studies.
Using AmericasDoctor.com is an innovative approach to help alleviate this
problem.

3/22/99 press release:

PHILADELPHIA, March 22 /PRNewswire/ -- Premier Research Worldwide, Ltd. (Nasdaq: PRWW - news), a Philadelphia based clinical research organization (CRO) announced today the signing of a 2 year, $4.6 million consulting agreement with America's Doctor to enhance this Internet company's capability to effectively support patient identification, recruitment and referral to clinical investigational sites for both PRWW and other companies in the pharmaceutical, biotechnology and medical device industries.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext